Skip to content
Align Technology Inc icon

Align Technology Inc

ALGNStocksMedical SpecialtiesUnited StatesNasdaqUSD

Price

$142.47

Today

-0.7%

YTD

-8.5%

About

Established in 1997, Align Technology Inc is a global medical device company focused on orthodontic and restorative treatments. The company is headquartered in San Jose, California. It offers dental solutions that combine advanced 3D modelling for digital treatment planning, shape engineering based on biomechanical principles, and mass customisation and 3D printing. Company solutions include the Invisalign system, an advanced clear aligner system, and the iTero intraoral scanners. Align Technology serves customers in over 100 countries and solves a wide range of needs, from simple tooth alignment to complex corrections, helping over six million patients worldwide. The enterprise operates across Clear Aligner, and Scanner and Services segments. The company has provided treatment to approximately 10.9 million patients using the Invisalign system. It provides innovative solutions in digital dentistry with the iTero intraoral scanner, which is helping to modernise today's practises by facilitating digital orthodontic and restorative workflows for improved patient outcomes and increased practise efficiencies. The firm trades on the NASDAQ under the ticker ALGN. In September 2021, Align Technology introduced the world's first professional whitening system optimised for Invisalign Aligners and Vivera Retainers, being fuelled by Ultradent's Opalescence Tooth Whitening Systems. Follow Align Technology using your eToro watchlist for updates and news on the current ALGN stock value.

Price chart
Closing price history for ALGN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)24.90
P/S (TTM)2.48
P/B (TTM)2.42
Market cap$10.20B
Cap tierLarge-cap
Industry avg P/E17.61

Profitability

Gross margin70.65%
EBIT margin18.38%
Net margin10.25%
ROE10.16%
ROA6.55%

Earnings & Revenue

Revenue (TTM)$4.14B
Revenue growth (1Y)+4.4%
EPS (TTM)$5.76
Free cash flow$633.57M
Total debt$120.84M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.43
Employees20,290
Next earnings28 Oct '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.